Company filings profile · CIK 0001444192

Grace Therapeutics, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Grace Therapeutics, Inc. (GRCE): 8 filings in the last 90 days vs 10 in the prior 90 (filing-velocity cooling ↓ · 0.8×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Jun 21, 2026. Source-linked, daily-refreshed.

Material 8-K events — Grace Therapeutics, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Jun 18, 2026Other Events; Financial Statements and Exhibits
Jun 18, 2026Results of Operations (earnings); Financial Statements and Exhibits
Jun 5, 2026Departure/Election of Directors or Officers; Financial Statements and Exhibits
Apr 27, 2026Other Events; Financial Statements and Exhibits
Apr 23, 2026Other Events; Financial Statements and Exhibits
Feb 12, 2026Results of Operations (earnings); Financial Statements and Exhibits
Jan 12, 2026Departure/Election of Directors or Officers; Financial Statements and Exhibits
Nov 13, 2025Results of Operations (earnings); Other Events; Financial Statements and Exhibits
Oct 23, 2025Other Events; Financial Statements and Exhibits
Sep 18, 2025Other Events; Financial Statements and Exhibits
Sep 12, 2025Item 5.07
Aug 27, 2025Other Events; Financial Statements and Exhibits
Aug 12, 2025Results of Operations (earnings); Financial Statements and Exhibits
Jun 25, 2025Other Events; Financial Statements and Exhibits
Jun 23, 2025Results of Operations (earnings); Financial Statements and Exhibits

Watch Grace Therapeutics, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Jan 12, 20264
Jan 12, 20264
Jan 12, 20264
Jan 12, 20264
May 13, 20254
May 13, 20254
May 13, 20254
May 13, 20254
Apr 16, 20254
Apr 16, 20254
Apr 16, 20254
Apr 16, 20254
Apr 16, 20254

Recent filings

FiledFormDetail
Jun 18, 20268-K Other Events; Financial Statements and Exhibits
Jun 18, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
Jun 18, 202610-K 10-K
Jun 5, 20268-K Departure/Election of Directors or Officers; Financial Statements and Exhibits
May 15, 2026SCHEDULE 13G/A
Apr 27, 2026SCHEDULE 13G/A
Apr 27, 20268-K Other Events; Financial Statements and Exhibits
Apr 23, 20268-K Other Events; Financial Statements and Exhibits
Feb 17, 2026SCHEDULE 13G/A
Feb 13, 2026SCHEDULE 13G/A
Feb 12, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
Feb 12, 202610-Q 10-Q
Jan 28, 2026SCHEDULE 13G/A
Jan 12, 20268-K Departure/Election of Directors or Officers; Financial Statements and Exhibits
Jan 12, 20264 FORM 4
Jan 12, 20264 FORM 4
Jan 12, 20264 FORM 4
Jan 12, 20264 FORM 4
Nov 17, 202510-Q/A 10Q/A
Nov 14, 2025SCHEDULE 13G/A
Nov 13, 20258-K Results of Operations (earnings); Other Events; Financial Statements and Exhibits
Nov 13, 202510-Q 10-Q
Oct 23, 20258-K Other Events; Financial Statements and Exhibits
Sep 18, 20258-K Other Events; Financial Statements and Exhibits
Sep 12, 20258-K Item 5.07
Aug 27, 20258-K Other Events; Financial Statements and Exhibits
Aug 14, 2025SCHEDULE 13G/A
Aug 12, 20258-K Results of Operations (earnings); Financial Statements and Exhibits
Aug 12, 202510-Q 10-Q
Jul 28, 2025DEFA14A DEFA14A
Jul 28, 2025DEF 14A DEF 14A
Jun 25, 20258-K Other Events; Financial Statements and Exhibits
Jun 23, 20258-K Results of Operations (earnings); Financial Statements and Exhibits
Jun 23, 202510-K ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D)
May 15, 2025SCHEDULE 13G/A
May 15, 2025SCHEDULE 13G
May 13, 20254 FORM 4
May 13, 20254 FORM 4
May 13, 20254 FORM 4
May 13, 20254 FORM 4